Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Chris Estes"'
Autor:
Sarah Blach, Kimberly A. Brown, Robert S. Brown, Pierre M. Gholam, Norah A. Terrault, Chris Estes, Homie A. Razavi
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 1, Pp 64-70 (2023)
Background: As of 2019, the United States (US) was not on track to achieve targets for elimination, due to increasing incidence and treatment barriers. In 2020, the COVID-19 pandemic disrupted HCV services globally and in the US. As healthcare servic
Externí odkaz:
https://doaj.org/article/3abc5c2eb6014217b655a09cfa31abfe
Autor:
Nicolas Goossens, Stefano Bellentani, Andreas Cerny, Jean-Francois Dufour, François R. Jornayvaz, Joachim Mertens, Alberto Moriggia, Beat Muellhaupt, Francesco Negro, Homie Razavi, David Semela, Chris Estes
Publikováno v:
Swiss Medical Weekly, Vol 149, Iss 5152 (2019)
As a result of epidemic levels of obesity and diabetes mellitus, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) will contribute to increases in the liver-related disease burden in Switzerland. A Markov model was bu
Externí odkaz:
https://doaj.org/article/deeb3b7fe4b7445dadc834028aa05e2c
Autor:
Khalid Alswat, Abdulrahman A Aljumah, Faisal M Sanai, Faisal Abaalkhail, Mohamed Alghamdi, Waleed K Al Hamoudi, Abdullah Al Khathlan, Huda Al Quraishi, Ahmed Al Rifai, Mohamed Al Zaabi, Mohamed A Babatin, Chris Estes, Almoutaz Hashim, Homie Razavi
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 24, Iss 4, Pp 211-219 (2018)
Background/Aim: Due to epidemic levels of obesity and type 2 diabetes mellitus (DM), nonalcoholic fatty liver disease (NAFLD) and resulting nonalcoholic steatohepatitis (NASH) will be driving factors in liver disease burden in the coming years in Sau
Externí odkaz:
https://doaj.org/article/3aad780610b645a988e7e8cd66817399
Autor:
Paulo Roberto Abrão Ferreira, Carlos Eduardo Brandão-Mello, Chris Estes, Fernando Lopes Gonçales Júnior, Henrique Sérgio Moraes Coelho, Homie Razavi, Hugo Cheinquer, Fernando Herz Wolff, Maria Lúcia Gomes Ferraz, Mário Guimarães Pessoa, Maria Cássia Mendes-Correa
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 19, Iss 4, Pp 363-368 (2015)
Background: Hepatitis C virus infection is a major cause of cirrhosis; hepatocellular carcinoma; and liver transplantation. The aim of this study was to estimate hepatitis C virus disease progression and the burden of disease from a nationwide perspe
Externí odkaz:
https://doaj.org/article/dfe61cc9996942de92a5f91139dee5b1
Autor:
Robert P Myers, Mel Krajden, Marc Bilodeau, Kelly Kaita, Paul Marotta, Kevork Peltekian, Alnoor Ramji, Chris Estes, Homie Razavi, Morris Sherman
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 28, Iss 5, Pp 243-250 (2014)
BACKGROUND: Chronic infection with hepatitis C virus (HCV) is a major cause of cirrhosis, hepatocellular carcinoma and liver transplantation.
Externí odkaz:
https://doaj.org/article/12e42d5b2cd04343afaf30cdb7260649
Autor:
Mia J. Biondi, Chris Estes, Devin Razavi-Shearer, Kanwar Sahdra, Nechama Lipton, Hemant Shah, Camelia Capraru, Harry L.A. Janssen, Homie Razavi, Jordan J. Feld
Publikováno v:
CMAJ Open. 11:E24-E32
Autor:
Erkin Musabaev, Chris Estes, Shakhlo Sadirova, Shokhista Bakieva, Krestina Brigida, Rick Dunn, Shyamasundaran Kottilil, Poonam Mathur, Ameer Abutaleb, Kathryn Razavi‐Shearer, Tim Anstiss, Bakhodir Yusupaliev, Homie Razavi
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver.
Chronic infection with hepatitis B and C viruses (HBVHCV) is a major contributor to liver disease and liver-related mortality in Uzbekistan. There is a need to demonstrate the feasibility of large-scale simplified testing and treatment to implement a
Autor:
Devin Razavi-Shearer, Ivane Gamkrelidze, Calvin Q. Pan, Kathryn Razavi-Shearer, Sarah Blach, Chris Estes, Ellen Mooneyhan, Homie Razavi
Publikováno v:
The Lancet Regional Health - Americas. 22:100516
Autor:
Sarah Blach, Kimberly A. Brown, Robert S. Brown, Pierre M. Gholam, Norah A. Terrault, Chris Estes, Homie A. Razavi
Publikováno v:
Journal of infection and public health. 16(1)
As of 2019, the United States (US) was not on track to achieve targets for elimination, due to increasing incidence and treatment barriers. In 2020, the COVID-19 pandemic disrupted HCV services globally and in the US. As healthcare services normalize
Autor:
Sarah Robbins-Scott, Ellen Dugan, Jonathan Schmelzer, Kathryn Razavi-Shearer, Mia J. Biondi, Sarah Blach, Poonam Mathur, Chris Estes, Siya Ma, Zongzhen Cai, Devin Razavi-Shearer, Homie Razavi, Shauna Montoya, Shyamasundaran Kottilil, Ivane Gamkrelidze, Jordan J. Feld, Mindi DePaola
Publikováno v:
The Lancet Gastroenterology & Hepatology. 6:169-184
Summary Background Treatment for infection with hepatitis C virus (HCV) during pregnancy has not yet been approved; however, interventions specifically targeting women, especially those of childbearing age (15–49 years), could prevent vertical tran